Fekkar, Arnaud

Fatal Invasive Aspergillosis and Coronavirus Disease in an Immunocompetent Patient

Blaize, M., Mayaux, J., Nabet, C., Lampros, A., Marcelin, A.-G., Thellier, M., Piarroux, R., Demoule, A., & Fekkar, A. (2020) · Emerging infectious diseases

Antifungal resistance and susceptibilityCOVID-19 Clinical Research Studies

Cited by 142

Biosynthesis of cell wall mannan in the conidium and the mycelium of Aspergillusfumigatus

Henry, C., Fontaine, T., Heddergott, C., Robinet, P., Aimanianda, V., Beau, R., Beauvais, A., Mouyna, I., Prevost, M.-C., Fekkar, A., et al. (2016) · Cellular Microbiology

Fungal and yeast genetics researchAntifungal resistance and susceptibility

Cited by 59

Rapid emergence of echinocandin resistance during Candida kefyr fungemia treatment with caspofungin

Fekkar, A., Meyer, I., Brossas, J. Y., Dannaoui, E., Palous, M., Uzunov, M., Nguyen, S., Leblond, V., Mazier, D., & Datry, A. (2013) · Antimicrobial Agents and Chemotherapy

Antifungal resistance and susceptibilityFungal Plant Pathogen Control

Cited by 56

Aspergillus fumigatus harbouring the sole Y121F mutation shows decreased susceptibility to voriconazole but maintained susceptibility to itraconazole and posaconazole

Lescar, J., Meyer, I., Akshita, K., Srinivasaraghavan, K., Verma, C., Palous, M., Mazier, D., Datry, A., & Fekkar, A. (2014) · Journal of Antimicrobial Chemotherapy

Antifungal resistance and susceptibilityFungal Plant Pathogen Control

Cited by 54